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Sphingosine-1-phosphate (S1P), produced by sphingosine
kinase 1 (SphK1) or kinase 2 (SphK2), mediates biological
effects through intracellular and/or extracellular mechanisms.
Here we determined a role for these kinases in kidney injury
of wild-type mice following ischemia–reperfusion. SphK1 but
not SphK2 mRNA expression and activity increased in the
kidney following injury relative to sham-operated animals.
Although SphK1/ mice had no alteration in renal function
following injury, mice with a disrupted SphK2 gene
(SphK2tr/tr) had histological damage and impaired function.
The immune-modulating pro-drug, FTY720, an S1P agonist
failed to provide protection in SphK2tr/tr mice. Injured kidneys
of these mice showed increased neutrophil infiltration and
neutrophil chemokine expression along with a 3- to 5-fold
increase in expression of the G-protein-coupled receptor
S1P3 compared to heterozygous SphK2
þ /tr mice. Kidney
function and reduced vascular permeability were
preserved in S1P3
/ compared to S1P3
þ / mice after
ischemia–reperfusion injury, suggesting increased S1P3
mRNA may play a role in the injury of SphK2tr/tr mice. Our
study suggests that constitutive expression of SphK2 may
contribute to reduced ischemia–reperfusion injury of the
kidney, and its absence may enhance injury due to increased
neutrophil infiltration and S1P3 activation. We also confirm
that SphK2 is necessary to mediate the protective effects
of FTY720.
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Ischemic acute kidney injury is a major clinical problem with
high morbidity and mortality and also accounts for delayed
graft function of transplanted kidneys.1,2 Treatment of
ischemic acute kidney injury still remains largely supportive
and many drugs that reduced injury in animal models have
failed in humans.3 Therefore, a refined understanding of the
mechanisms of kidney ischemia–reperfusion injury (IRI) and
development and testing of novel compounds is necessary.
Sphingosine-1-phosphate (S1P), a pleiotrophic lipid
mediator is produced by phosphorylation of sphingosine by
sphingosine kinases (SphKs) in response to a variety of
stimuli. S1P is exported out of the cell (inside-out signaling)
and serves as a ligand for five different G-protein-coupled
receptors (S1P15).
4 In addition to extracellular function,
S1P also has an intracellular role and acts as a second
messenger.5,6 S1P regulates diverse biological processes and
functions, including cell growth, survival, and proliferation
and angiogenesis; S1P inhibits apoptosis and effects lympho-
cyte trafficking.7–12 Furthermore, S1P1 receptor activation has
been shown to protect kidneys from IRI.13,14
SphK1 and SphK2 are important rate-limiting steps in the
formation of S1P. Despite sharing two large conserved
regions, these kinases have different kinetics of expression
during development as well as different subcellular localiza-
tion,15,16 suggesting that these two isoforms may serve
different functions. SphK1 promotes cell-survival, prolifera-
tion, and regulates cell transformation.17 In contrast, less is
known about SphK2, although several reports suggest that
SphK2 serves proapoptotic functions.18,19 More importantly,
SphK2 phosphorylates FTY720,20 an immune modulatory
prodrug currently in clinical trials for multiple sclerosis. Mice
deficient in SphK1 or SphK2 do not exhibit conspicuous
abnormalities, whereas double knockouts are lethal.21 The
purpose of the current study was to investigate the role of
SphK1 and SphK2 in kidney IRI and to determine the role of
SphK2 in mediating the kidney-protective effect of FTY720.
RESULTS
SphK gene expression and enzyme activities after kidney IRI
We first examined SphK1 and SphK2 gene expression and
enzyme activities at various time points after kidney IR in
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wild-type (WT) mice. SphK1 mRNA expression showed a
robust increase as early as 2 h after reperfusion, peaking at
4–6 h with a 30-fold higher level compared to sham-operated
mice and remaining elevated until 96 h. In contrast to the
SphK1 mRNA, SphK2 mRNA did not increase significantly
after IRI (Figure 1a). As expected from changes in cognate
mRNA levels, SphK1 enzyme activity increased by threefold
but there was no significant change in SphK2 enzyme activity
(Figure 1b). These findings demonstrate that kidney IRI
induces an increase in steady-state kidney SphK1 mRNA but
not SphK2 mRNA, suggesting that SphK1 may be important
in injury following kidney IR.
The effects of SphK1 and SphK2 on renal injury
To determine the importance of the SphK1 and SphK2 gene
products in renal injury, we first evaluated functional and
histological changes in Sphk1/ and SphK2tr/tr mice. We
assumed that the marked increase in SphK1 activity following
kidney IRI indicated an important role of this enzyme in the
kidney. Unexpectedly, the increase in plasma creatinine in
SphK1/ mice following kidney IR was not significantly
different from that in SphK1þ /þ mice (Figure 2a). Surpris-
ingly, although SphK2 gene expression and enzyme activity
were unchanged after kidney IR, kidney injury at 24 h was
worse in SphK2tr/tr as indicated by elevated plasma creatinine
levels that were significantly greater in SphK2tr/tr than in
SphK2þ /tr or WT mice (Figure 2b). Histological examination
with hematoxylin and eosin staining showed extensive
tubular injury characterized by an increase in tubular cell
necrosis, dilation of tubules, and cast formation in the outer
medulla of SphK2tr/tr mice. Kidneys from SphK2þ /tr and/or
WT showed less tubular injury compared to SphK2tr/tr
(Figure 3a). A semiquantitative assessment demonstrated
histological damage was greater in SphK2tr/tr than in
SphK2þ /tr mice (Figure 3b).
Compensatory SphK mRNA expression in SphK-deficient
mice
To examine the possibility that compensatory changes in
expression of SphKs may occur in SphK null mice, we measured
SphK1 mRNA expression in SphK2tr/tr and SphK2 mRNA
expression in SphK1/ after 6 h of reperfusion in sham and IR
mice. Although the marked increase in expression of SphK1 and
SphK2, as shown in Figure 1, was confirmed in this experiment,
there were no significant differences in the magnitude of the
increase in SphK1 mRNA in SphK2tr/tr compared to SphK2þ /tr
mice or in SphK2 mRNA in SphK1/ compared to SphK1þ /þ
mice (Figure 4a and b). These results suggest that following
kidney IRI, a compensatory mechanism between SphK1 and
SphK2 does not occur when one enzyme is absent.
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Figure 1 | Time course of SphK mRNA expression and enzyme
activities in kidney IRI. Mouse kidneys were subjected to 32 min
of ischemia and at various time points after reperfusion, kidneys
were harvested for RNA extraction and measurement of SphK
enzyme activities. Values are mean±s.e.m.; n¼ 4–5 for each
group; *Po0.05 compared with sham. (a) Time course of SphK
mRNA expression following kidney IRI; (b) Time course of SphK
enzyme activities following kidney IRI.
SphK2 tr/tr SphK2 +/tr WT
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
0.0
Pl
as
m
a 
cr
ea
tin
in
e 
(m
g/1
00
 m
l)
Pl
as
m
a 
cr
ea
tin
in
e 
(m
g/1
00
 m
l)
*
Sham
IR
Sham
IR
SphK1–/–SphK1+/+
0.2
0.4
0.6
0.8
1.0
1.2
Figure 2 | Effect of the absence of SphK1 and SphK2 on
plasma creatinine in kidney IRI. Kidneys from (a) SphK1
(SphK1/ and SphK1þ /þ ) or (b) SphK2 (SphK2tr/tr SphK2þ /tr and
WT) mice were subjected to 32 min of ischemia and plasma
creatinine concentrations were measured after 24 h of
reperfusion. Values are mean±s.e.m.; n¼ 4–5 for each group;
*Po0.05 compared with SphK2þ /tr in (b).
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Enhanced cell death in SphK2 in kidney IRI
Our results with SphK2tr/tr mice, which suggest a role for
SphK2 rather than SphK1 in kidney IRI, prompted further
studies on SphK2. Together with necrosis, apoptosis is also an
important mode of cell death following IR. We measured the
number of terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling (TUNEL)-positive cells in kidneys
following IRI and found that, unlike tubular cell necrosis,
there was no significant difference in the increased number of
apoptotic cells at 6 (Figure 5a and b) and 24 h (data not
shown) post reperfusion in SphK2tr/tr compared to SphK2þ /tr
mice. Also, total kidney protein from sham or IR SphK2tr/tr
and SphK2þ /tr mice at 6 and 24 h reperfusion was used to
assess apoptosis by western blot analysis using activated
caspase 3 antibody. No significant changes in cleaved forms
of caspase 3 were noted in SphK2tr/tr and SphK2þ /tr mice;
similarly no significant changes in mRNA levels of bax/bcl-2
ratio at 6 and 24 h were observed (data not shown).
The absence of SphK2 increases kidney neutrophil infiltration
and neutrophil chemoattractants following kidney IRI
Kidney sections from SphK2tr/tr and SphK2þ /tr were labeled
immunohistochemically to assess neutrophil infiltration 24 h
following kidney IRI. A marked increase in neutrophil
infiltration following kidney IRI was seen primarily in the
outer medulla (Figure 6a). Kidneys from SphK2tr/tr mice had
significantly more neutrophil infiltration compared with
SphK2þ /tr mice (Figure 6b). We also examined neutrophil
infiltration 24 h following kidney IR in SphK1/ and
SphK1þ /þ mice. Consistent with the finding that there was
no difference in plasma creatinine following kidney IRI in
SphK1/ and SphK1þ /þ mice, we observed no difference in
neutrophil infiltration between these two groups (Figure 6a
and b). Similarly, the kidney sections from SphK1 and SphK2
were labeled for infiltrating monocytes (F4/80-positive cells).
No difference in the number of infiltrating monocytes was
observed between SphK1/ and SphK2tr/tr IR (data not
shown).
With our observation that kidney neutrophil infiltration
was greater following IR in SphK2tr/tr compared with
SphK2þ /tr mice, we sought to determine whether neutrophil
chemoattractant expression was increased in SphK2tr/tr
compared with SphK2þ /tr mice. mRNA of neutrophil
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Figure 3 | Effect of the absence of SphK2 on histology in IR-induced acute kidney injury. (a) Mouse kidneys from SphK2tr/tr or SphK2þ /tr
mice were subjected to 32 min of ischemia or sham surgery, and kidneys were harvested after 24 h of reperfusion and processed for
histological examination of sections of kidney outer medulla under  200 magnification. (b) Semiquantitative assessment of histological
damage. Values are mean±s.e.m.; n¼ 4–5 for each group. *Po0.05 compared with SphK2tr/tr.
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Figure 4 | Changes in SphK1 mRNA expression in SphKtr/tr and
SphKþ /tr mice and SphK2 mRNA expression in SphKþ /þ and
SphK/ mice. Mouse kidneys from SphK1/, SphK1þ /þ ,
SphK2tr/tr, or SphK2þ /tr mice were subjected to 32 min of ischemia
and 6 h of reperfusion. RNA was extracted and quantitative real-
time RT-PCR was performed. (a) SphK1 mRNA in SphK2tr/tr and
SphK2þ /tr mice and (b) SphK2 mRNA in SphK1/ and SphK1þ /þ
mice are shown as fold change compared to sham; n¼ 4–5 for
each group.
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chemoattractants, CXCL1, CXCL2, and CXCL5 was assessed
in SphK2tr/tr and SphK2þ /tr mice at 6 and 24 h post
reperfusion (Figure 7). Kidney IRI led to an increase in
CXCL1 and CXCL2 mRNA at both 6 and 24 h following
kidney IRI in SphK2 mice; the increase in CXCL1 expression
was significantly greater in SphK2tr/tr compared to SphK2þ /tr
mice (Figure 7a and b). CXCL5 mRNA expression, however,
was reduced in the SphK2tr/tr mice compared to SphK2þ /tr at
6 and 24 h following IRI (Figure 7c). In SphK1 mice no
significant difference in neutrophil chemoattractant expres-
sion was observed between SphK1/ and SphK1þ /þ mice
(data not shown). Furthermore, the expression of several
proinflammatory cytokine and chemokine genes in SphK2tr/tr
and SphK2þ /tr mice was examined at 24 h following IRI.
Tumor necrosis factor-a, interleukin-6 and monocyte
chemoattractant protein-1 mRNA expression markedly
increased at 24 h after IR in both SphK2tr/tr and SphK2þ /tr
mice compared to sham. However, there were no significant
differences in mRNA levels between the SphK2tr/tr and
SphK2þ /tr mice (data not shown).
S1P3 receptor role in mediating IRI injury in SphK2
tr/tr
S1P1 receptor activation by selective agonists following
kidney IR has been documented to be protective,13,14 whereas
S1P3 activation may lead to injury.
22 Thus, we sought to
determine the effect of IRI on expression of S1P1 and S1P3
receptors in SphK2tr/tr and SphK2þ /tr mice. S1P1 mRNA
increased markedly at 6 and 24 h following IRI in SphK2 mice
and the magnitude of the increase was greater in SphK2tr/tr
than in SphK2þ /tr (Figure 8a). S1P3 mRNA was not affected
by IRI in SphK2þ /tr but increased significantly in SphK2tr/tr
mice (Figure 8b). Thus, although SphK2tr/tr and SphK2þ /tr
mice show increased expression of S1P1 mRNA following
kidney IRI, a response that may be protective, only the
SphK2tr/tr mice demonstrated heightened expression of S1P3
mRNA, a response that may be deleterious. To test this
hypothesis we performed IR in S1P3
/, S1P3
þ /, and S1P3
þ /þ
mice and found that plasma creatinine levels 24 h
following reperfusion were significantly lower in S1P3
/
than S1P3
þ / and S1P3
þ /þ mice (Figure 8c). We next
determined whether IRI in S1P3
/ was associated with
reduced vascular permeability by measuring kidney Evan’s
blue dye content. S1P3
/ mice had reduced Evan’s blue dye
content following IRI consistent with a more intact vascular
barrier than S1P3
þ / (Figure 8d). These results are consistent
with results by Gon et al.22 who found that pulmonary
permeability and injury was reduced in S1P3
/ mice.
The effect of absence of SphK2 gene on FTY720-mediated
renal tissue protection
SphK2 is required for modulation of lymphocyte traffic by
FTY720.13 To test the hypothesis that SphK2 is necessary in
mediating the protective effect of FTY720, we administered
FTY720 in SphK2tr/tr SphK2þ /tr and WT mice. In contrast to
WT mice, there was no protective effect of FTY720 in
SphK2tr/tr or SphK2þ /tr mice, indicating that SphK2 is
required for mediating the protective effect of FTY720
(Figure 9a). However, administration of exogenous S1P
reduced kidney IRI in the absence of SphK2 (Figure 9b).
DISCUSSION
In this study, we demonstrated that the absence of SphK2,
but not SphK1, was associated with worse kidney damage
after IRI. This result is counter to the observation that SphK1
but not SphK2 mRNA and activity increased in kidney
subsequent to IRI. In WT mice SphK2 showed minimal
regulation of mRNA and enzymatic activity after IRI. The
more severe kidney IRI in SphK2tr/tr mice was associated with
an increase in neutrophils and neutrophil chemoattractants
and an increase in S1P3 mRNA expression. Heightened S1P3
expression may have had a deleterious effect in SphK2tr/tr
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Figure 5 | Effect of SphK2 on apoptosis in kidney IRI. Mouse
kidneys from SphK2tr/tr or SphK2þ /tr mice were subjected to
32 min of ischemia and kidneys were harvested after 6 h of
reperfusion. (a, b) Sections of kidney (200 magnification)
processed for detection of apoptosis using TUNEL staining
(TUNEL-positive cells contain brown immunoperoxidase reaction
product) and counterstained blue with hematoxylin. (c)
Quantitative analysis (n¼ 3–4) for each group of TUNEL-positive
cells in kidneys from SphK2tr/tr or SphK2þ /tr mice.
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mice, as kidney function following IR in S1P3
/ mice was
markedly protected and was associated with reduced vascular
permeability. Our result suggests that constitutive expression
of SphK2 is important in determining cell survival. However,
in contrast to SphK2, the absence of SphK1 did not affect
kidney damage. Lastly, we found that SphK2 is important in
mediating the tissue-protective effect of FTY720 in IR-
induced kidney injury, indicating that FTY720 phosphate is
the active agent in protecting the kidney from IRI.
S1P is an emerging lipid signaling molecule that is
important in diverse biological processes.7–9,11,12,23 SphK1
and SphK2 regulate levels of S1P, therefore we first examined
SphK1 and SphK2 gene expressions and enzyme activities
following kidney IR. Although SphK1 mRNA showed a
marked increase shortly after reperfusion, SphK2 mRNA
showed minimal changes. This finding suggested that SphK1
could be important in kidney IRI. To test this possibility, we
induced kidney IRI in SphK1 and SphK2 null mice.
Unexpectedly, the absence of SphK1 did not affect renal
function 24 h after reperfusion despite a marked increase in
SphK1 gene expression and activity in WT mice. In contrast,
however, IRI led to worse injury in SphK2tr/tr mice compared
with WT or SphK2þ /tr mice. These findings were unexpected
given that in vitro studies have demonstrated prosurvival and
proapoptotic effects of SphK1 and SphK2, respec-
tively.15,18,19,24 However, there is a possibility that the absence
of any effect of SphK1 gene can be related to the fact that the
function of SphK1 requires translocation to a specific
membrane compartment. The majority of SphK1 activity is
localized to the cytosol and on stimulation, it must travel to
the plasma membrane to synthesize S1P. Kusner et al.25
showed SphK1 was co-localized with actin filaments at
macrophage plasma membranes. Disruption of actin poly-
merization reduced plasma membrane SphK1 activity
demonstrating that actin filaments are involved in SphK1
localization and regulation of activity. Following kidney IRI,
proximal tubule epithelial and endothelial actin filaments are
disrupted.,26,27 Thus, despite the marked increase in SphK1
mRNA expression and enzyme activity in kidneys of mice
subjected to kidney IRI, translocation of SphK1 to critical
intracellular sites in injured epithelial or endothelial cells may
have been blocked, thereby preventing any change in kidney
function and histology following kidney IRI. Finally,
subcellular localization of SphKs may have an important
role in production of S1P and its role in kidney IRI.
By contrast, cell survival following kidney IRI appears to
require constitutive expression of SphK2. Compared to WT
or SphK2þ /tr SphK2tr/tr mice had more severe kidney damage
following IR. Insofar as innate mechanisms participate in
kidney IRI,28,29 analogous results have been shown in
bacterial infections. In a model of bacterial lung infection,
the extent of disease was worse in SphK2 null mice in
comparison to SphK1 null mice.30
Apoptosis does not explain the difference in extent of
kidney IRI in SphK2tr/tr compared to SphK2þ /tr mice,
suggesting that SphK2 has different effects on cell death
pathways. Change in SphK2 did not affect the increase in the
levels of expression of the proinflammatory cytokines (tumor
necrosis factor-a, interleukin-6 and monocyte chemoattrac-
tant protein-1), suggesting SphK2 does not affect key
surrogate markers of inflammation. However, it should be
noted that our assays were limited to whole kidney mRNA
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expression. It is possible that selective S1P deficiency from
immune cells isolated from SphK2tr/tr mice may have been
altered although the overall effect on inflammation in IRI
kidneys was not.
Kidney IRI in SphK2tr/tr mice was associated with an
increase in infiltration of neutrophils and neutrophil
chemoattractants such as CXCL1 and CXCL2. In SphK1/
that had a similar level of injury compared to SphKþ /þ mice,
there was no change in number of neutrophils infiltrating the
kidney or in neutrophil chemoattractants as compared to the
SphK2tr/tr mice. Activation of SphK is likely to increase S1P
levels and in its absence there may be an increase in ceramide/
sphingosine levels. Because these sphingolipid metabolites
have opposite actions, the concept of a ‘sphingolipid rheostat’
has been developed that addresses the importance of balance
of these mediators and not the absolute amount of
metabolites in determining the ultimate cell fate.31 S1P
inhibits transendothelial migration of neutrophils and is
thought to be an effective motility regulator of human
neutrophils32 through a reduction in neutrophil chemoat-
tractants, CXLC1 (homologue of human interleukin-8)33,34
and CXCL2.35 Thus, our findings that kidney IRI in SphK2tr/tr
mice (and presumably a decrease in S1P in critical areas) was
associated with an increase in kidney injury, neutrophil
infiltration, and increased CXCL1 and CXCL2 expression are
consistent with these reports.
S1P, produced by SphK, mainly functions by binding to
S1P receptors. Activation of S1P1 has been recently shown to
reduce kidney IRI.13,14 Activated S1P1-induced peripheral
lymphopenia with a subsequent decrease in T-cell infiltration
into kidney is thought to be important. In our study, we
found S1P1 and also S1P3 gene expression increased markedly
in SphK2tr/tr mice. Although the increase in S1P1 may serve to
reduce injury, the increase in S1P3 may not. Although S1P
activation of S1P1 mediates cortical actin reassembly by Rac
activation and leads to endothelial barrier enhancement, S1P3
activation in pulmonary epithelial cells leads to disruption of
tight junctions, possibly by activating Rho, resulting in
increased lung vascular permeability.22,36,37 S1P3 KO mice
however were protected.22 Thus, it may be possible that S1P3
activation after kidney IRI negatively regulates endothelial or
epithelial barrier function and that marked increase of S1P3
in SphK2tr/tr mice might be responsible for worse renal
injury. In support of this possibility we have observed that
the protective effect of FTY720 reduces kidney IRI and
vascular permeability through the activation of S1P1
receptors.13 However, the protective effect of FTY720 on
kidney IRI and vascular permeability is lost with high doses
of FTY720 that may in part be due to effects on S1P3
receptors (M.D. Okusa and A.E. Awad). To directly test this
possibility we performed kidney IRI in S1P3
/ mice and
found that these mice were protected from injury and the
ischemic kidneys demonstrated reduced vascular permeabil-
ity compared to S1P3
þ / mice. Thus, the increase in S1P3
expression following kidney IRI in SphK2tr/tr mice could have
led to enhanced injury.
FTY720 is phosphorylated in vivo by SphK2 to form the
active principle, FTY720-P.20 Although necessary for FTY720
induced lymphopenia,38–40 the importance of FTY720
phosphorylation in reducing kidney IRI has not previously
been tested. We found that FTY720 did not have a protective
effect in SphK2tr/tr or in SphK2þ tr confirming the necessity of
SphK2 in mediating FTY720-induced protection in kidney
IRI. This further confirms the possibility that S1P receptor
activation is necessary for the protective effects of S1P and/or
its receptor agonist, FTY720.
In summary, we showed that the absence of SphK2 was
associated with more severe kidney damage after IR. This
finding suggests that despite minimal regulation of SphK2
after IR, constitutive expression of SphK2 is essential for cell-
survival pathways after injury. However, the absence of
SphK2 was not associated with increased apoptotic cell death
(measured by TUNEL and western blot for cleaved caspase
3), but appeared to be important in neutrophil infiltration
into inflamed kidneys through an increase in neutrophil
chemoattractants. Furthermore, the absence of SphK2
enhanced expression of kidney S1P3 following IRI and
increased vascular permeability following IRI, an observation
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Figure 7 | Effect of SphK2 on neutrophil chemokines in IR
kidney. Mouse kidneys from SphK2tr/tr and SphK2þ /tr mice were
subjected to 32 min of ischemia and were harvested for RNA at 6
and 24 h after reperfusion. Neutrophil chemoattractant
chemokines CXCL1 (a), CXCL2 (b) and CXCL5 (c) mRNA were
measured using real-time RT-PCR. CXCL1 and CXCL2 mRNA levels
increased significantly in SphK2tr/tr mouse kidney compared to
SphK2þ /tr at 6 and 24 h. n¼ 2–3 for each group; ***Po0.001
compared to SphK2þ /tr.
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that could be in part responsible for the increase in injury. In
addition, SphK2 is thought to be important in mediating the
kidney-protective effects of FTY720, a novel immune
modulator. Sphingolipids are important constituents in
injury associated with kidney IRI necessitating further studies
to demonstrate the precise role of SphK, S1P, and S1P
receptors in kidney IRI. More refined knowledge on the role
of sphingolipids in kidney will likely lead to development of
new therapeutic drugs for treatment of ischemic acute kidney
injury in humans.
MATERIALS AND METHODS
Animals and IRI experimental protocol
All experiments were performed in accordance with the NIH Guide
for the Care and Use of Laboratory Animals. We used C57BL/6 mice
(B20 g, between 6 and 8 weeks of age; Charles River Laboratories,
Wilmington, MA, USA), SphKtr/tr and SphK2þ /tr mice (129/Sv X
C57BL/6) were generated and provided by Dr Kevin R. Lynch
(University of Virginia).20 SphK1/ and S1P3
/ mice (congenic on
C57BL/6) were provided by Dr Richard L. Proia (National Institutes
of Health). For SphK1/ mice, C57BL/6 mice served as WT
controls. Bilateral flank incisions were performed as previously
described.41 Mice were anesthetized and were placed on a
thermoregulated pad to maintain body temperature at 37 1C. Both
renal pedicles were exposed and cross-clamped for 32 (SphK1/2
mice) and 26 min (S1P3 mice), and then clamps were released to
allow for reperfusion for different times. In sham-operated mice,
renal pedicles were exposed but not clamped. At various time points
after reperfusion, blood was collected and tissues were processed for
molecular and histological examination.
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Figure 8 | S1P3 receptor gene expression in IR kidney. Mouse kidneys from SphK2
tr/tr or SphK2þ /tr mice were subjected to 32 min of
ischemia and 24 h after reperfusion, RNA was extracted and quantitative real-time RT-PCR for S1P1 and S1P3 was carried out. (a) S1P1 mRNA
and (b) S1P3 mRNA are expressed as fold change compared to sham. n¼ 4 for each group. *Po0.05 compared with sham; #Po0.05
compared to SphK2tr/tr. (c) Plasma creatinine at 24 h following kidney IRI for S1P3
þ /þ (n¼ 8), S1P3þ / (n¼ 6) and S1P3/ (n¼ 7) mice.
***Po0.001 compared to S1P3þ /þ ; #Po0.05 compared to S1P3þ /. (d) Evan’s blue dye was measured in S1P3/ (n¼ 7) and S1P3þ / (n¼ 7)
mice after IR. Values are shown relative to respective sham mice; **Po0.02 compared to S1P3þ /.
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Figure 9 | Effect of FTY720 on renal function in SphK2tr/tr mice.
Mouse kidneys from SphK2tr/tr or SphK2þ /tr mice were subjected
to 32 min of ischemia and plasma creatinine was measured after
24 h of reperfusion. (a) FTY720 (48 mg/kg, i.p.) (b) S1P (50 ng/kg,
i.v.) or vehicle (3% fatty acid–free bovine serum albumin/
phosphate-buffered saline solution; i.p.) was administered (see
‘Materials and Methods’). n¼ 4 for each group; *Po0.05
compared to vehicle.
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Drug treatment
Three doses (24, 20, and 1 h before ischemia) of FTY720 (48 mg/kg,
i.p.; Novartis, Basel, Switzerland) or vehicle (3% fatty acid-free
bovine serum albumin/phosphate-buffered saline solution) (Sigma,
St Louis, MO) were administered. S1P (Biomol International,
Plymouth Meeting, PA) from methanol stocks was air-dried and
dissolved in phosphate-buffered saline/1% bovine serum albumin
and administered (50 ng/kg, i.v.) 1 h before ischemia.
Biochemical and histological examination
Plasma creatinine was determined using a colorimetric assay
according to the manufacturer’s protocol (Sigma). For histological
examination, 4-mm sections of paraformaldehyde-fixed (4%) and
paraffin-embedded kidney tissues were stained with hematoxylin and
eosin. Briefly, semiquantitatively outer medulla tubular damage was
estimated in 8–10 high-power fields ( 200 magnification) per section
by using a scoring system based on the percentage of damaged tubules
per field (1p25%; 2¼ 25–50%; 3¼ 50–75%; and 4X75%), and the
mean scores of each mouse were compared. Apoptotic cells in the
kidney were detected using ApopTag Plus (Intergen, Purchase, NY)
on paraffin-embedded kidney tissue sections following the manu-
facturer’s protocol. The number of apoptotic cells in the outer
medulla and cortex was measured semiquantitatively by counting
8–10 high-power fields ( 200) per section, and the mean number of
TUNEL-positive cells was compared between groups.
Neutrophil labeling of kidney sections and quantification
Paraffin sections (5mm) were labeled with a rat monoclonal
antibody to murine neutrophils (clone 7/4; Caltag Laboratories,
Carlsbad, CA, USA, catalog no. RM6500 at 1:100) as previously
described.42 Photographs, taken and adjusted for brightness/
contrast with a SPOT RT camera (software version 3.3; Diagnostic
Instruments), were stored as TIF files and analyzed using Adobe
Photoshop CS2. Use of Photoshop allows the color of any individual
pixel to be sampled and set as foreground color. The select/color
range tools allow all pixels in the image having a color similar to the
foreground color to be selected and counted using the histogram
tool. An average of 5–6 different areas and 3–4 different mice were
analyzed and averaged.
Analysis of kidney vascular permeability
Changes in vascular permeability were assessed by measuring
extravasation of Evan’s blue dye into the kidney tissue as previously
described.13
Measurement of SphK activity
Kidney SphK activity was assessed as previously described.20 Briefly,
kidney homogenates were prepared and to determine the fractional
activity of SphK1 and SphK2, the buffer was supplemented with
either 0.05% Triton X-100 or 1 M KCl, respectively. Radiolabeled
enzyme products were detected by autoradiography and identified
by migration relative to authentic standards. For quantification, the
silica gel containing radiolabeled lipid was scraped into a
scintillation vial and counted.
Real-time RT-PCR
Total RNA and cDNA synthesis was performed as previously
described.13 Subsequently, real-time RT-PCR was run on the
MyCycler system (Bio-Rad, Hercules, CA, USA) with gene-specific
primer sets of mouse tumor necrosis factor-a (catalog no.
PPM03113), interleukin-6 (catalog no. PPM03015), monocyte
chemoattractant protein-1 (PPM03151), and glyceraldehyde-3-
phosphate dehydrogenase (catalog no. PPM02946) developed by
SuperArray Bioscience Corporation (Frederick, MD). Primer
sequences for mouse SphK1, SphK2, S1P1, S1P3, CXCL1, CXCL2,
and CXCL5 are shown in Table 1. The abundance of gene expression
was normalized to that of GAPDH.
Statistical analysis
Data were analyzed by SigmaStat 2.03 (San Jose, CA, USA) and
GraphPad InStat 3 presented as mean±s.e.m. Analysis was carried
out by using unpaired t-test or analysis of variance, and a P-value
less than 0.05 was considered statistically significant.
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